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Background: Saussurea involucrata (Kar. et Kir.) (S. involucrate), is a rare traditional Chinese medicinal herb. Rutin
and hispidulin as well as their metabolites are flavonoids of the flavonol type that abound in S. involucrata, which
has been reported to inhibit nonoxidative advanced glycation end products which was involved in physiological
inflammation. This study aims to investigate the role of 3,4-dihydroxytoluene (DHT), a metabolite of rutin, in
inflammatory inhibition and its involved mechanism.
Methods: This study utilized lipopolysaccharide (LPS) stimulated murine macrophage cell line RAW 264.7 as
inflammatory model. The inhibitory effects of DHT were evaluated by the expression level of several inflammation
markers such as inducible nitric oxide synthase (iNOS) and cyclooxygenase-2 (COX-2) in RAW264.7 after LPS treatment.
In addition, underlying mechanisms, the activation of mitogen-activated protein kinases (MAPKs) and NF-κB, were
also investigated.
Results: Our results showed that DHT significantly suppressed the LPS-induced production of nitric oxide (NO), iNOS,
and COX-2 in a dose-dependent manner without cytotoxicity. DHT also reduced the generation of proinflammatory
cytokines majorly in tumor necrosis factor (TNF)-α and minor in interleukin (IL)-1β and IL-6. In addition, LPS-stimulated
I-κBα phosphorylation and degradation followed by translocation of the nuclear factor κB (NF-kB)-p65 from the cytoplasm
to the nucleus were attenuated after DHT treatment.
Conclusions: Combined, the results suggest that DHT might exert anti-inflammatory effects in vitro in LPS stimulated
RAW 264.7 macrophages and is potential in adjuvant treatment in inflammation disease.
Keywords: Saussurea involucrata, Flavonoid, Anti-inflammation, Cyclooxygenase-2 (COX-2), Inducible nitric oxide synthaseBackground
Saussurea involucrata (Kar. et Kir.) (S. involucrata), known
as the snow lotus, grows in the rocky habitats of moun-
tains that reach or exceed an elevation of 2600 m in the
Tian Shan and A’er Tai areas of China. In recent years, the
wild population of S. involucrata has been facing the threat
of depletion due to their particularly slow growth and
excessively harvested from the wild for pharmaceutical
preparations. S. involucrata is now nearly extinct and has* Correspondence: a221865880@yahoo.com.tw
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reproduction in any medium, provided the orbeen listed as a second grade national protected wild plant
in China [1,2]. Based on the theories of traditional Chinese
medicine, S. involucrata has the effect of warming the kid-
neys, activating yang, expelling wind, eliminating dampness,
inducing menstruation, and promoting blood circulation.
In folk medicine, it is used to treat rheumatoid arthritis,
impotence, irregular menses, coughs and colds, stomach-
ache, and altitude sickness, among other illnesses [3,4].
Rutin (3,3’,4’,5,7-pentahydroxyflavone-3-rhamnoglucoside)
is a flavonoid of the flavonol type abundantly present
in S. involucrata. It has been reported that rutin has
several pharmacological properties, including antioxidant,
anticarcinogenic, cytoprotective, antiplatelet, antithrombotic,This is an open access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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as well as neuroprotective [11]. In addition, it also has
been demonstrated to have anticonvulsant properties in
pentylenetetrazol models in rats and mice [12]. In the
mention of antioxidative issue, our previous report showed
rutin can ameliorated ischemic reperfusion injuries in
the brain by reducing MDA level in plasma and elevat-
ing caspase-3 and PARP [13].
High oral doses of rutin (3,3’,4’,5,7-pentahydroxyflavone-
3-rhamnoglucoside) protected diabetic rats against the
formation of protein adducts in the skin [14]. Although
the precise mechanism of this protection is not known, lit-
tle or no dietary rutin is absorbed because gut microflora
in the large intestine metabolize rutin to a variety of
compounds that include quercetin and phenol deriva-
tives such as 3,4-dihydroxyphenylacetic acid (DHPAA),
3,4-dihydroxytoluene (DHT), -hydroxyphenylacetic acid
(HPAA), and 4-hydroxy-3-methoxyphenylacetic acid
(homovanillic acid, HVA) [15-20]. Pashikanti et. al.
reported that the rutin metabolites can efficiently and
powerfully inhibit fluorescent and nonfluorescent be-
long to advanced glycation end products (AGEs) [21].
Since AGEs were an important source of reactive dicar-
bonyl species (RCS) involved in several pathophysio-
logical conditions such as inflammation [22,23], we
hypothesized that the metabolites can reduce inflam-
matory response. More importantly, rutin can reduce
inflammatory cytokines such as IL-1 from the periton-
eal macrophages (pMf). [17] Most of the rutin that is
consumed is likely to be decomposed into low-molecular-
weight phenolic acids by the colonic microflora [24,25].
However, it had not been investigated what kind of
metabolites of rutin can have anti-inflammation effect.
In addition, it was evidenced that most of the protectiveFigure 1 Effects of rutin metabolites on NO production in LPS-stimula
RAW264.7 macrophage with rutin or its metabolites including DHT, DHPAA
measurement. (B) Cell cytotoxicity assay for DHT. RAW 264.7 was treated w
measure OD 570 nm by spectrophotometry. The data was expressed as theffects of flavonoids against oxidative stress in PC12
cells are continued despite biodegradation of the parent
flavonoids. Taken together, this background has led us
to examine the suppression of the inflammation effects
of dietary supplements using rutin’s derives, such as
DHPAA, DHT, HPAA, and HVA on LPS-induced inflam-
mation in macrophage cells.
In this study, we utilized Lipopolysaccharide (LPS)-
stimulated murine macrophage cell line RAW 264.7 as
inflammatory model to test the effects of rutin derives.
LPS can trigger groups of different toll-like receptors
(TLR) especially TLR4 expressed on the cell surface
of immune cells [26]. The binding of LPS to TLR4 trig-
gers down-stream signaling cascades, including mitogen-
activated protein kinases (MAPKs) [27] and the nuclear
transcription factor kappa-B (NF-B) pathways [28], which
lead to the production of inflammatory mediators from
macrophages, such as tumor necrosis factor-alpha (TNF-α),
interleukin-1 (IL-1), interleukin-6 (IL-6), and nitric oxide
(NO) [29]. Our results indicated DHT, the phenol derivative
of rutin, inhibited the NO, TNF-α in LPS-stimulated
macrophages through IκB-NF-κB signaling rather than
MAPK, ERK1/2, p38 and JNK1/2 pathways. These results
provided a model of DHT for anti-inflammation usage.
Methods
Preparation of fractions
The wild plant of S. involucrata used in this study was
a gift from Biopure Biotechnology (Changhua, Taiwan).
Twenty grams of dried aerial and flower parts S. involu-
crate was extracted with 100 mL of methanol three times
under reflux for 2 h. The methanol extracts (SI-1) were
combined, and the solvent was evaporated in vacuum to
give a deep brown syrup. The syrup was resuspended inted RAW 264.7 and DHT cytotoxicity test. (A) After LPS stimulation,
, HPAA and HVA treatment was assessed to NO production
ith DHT for 24 hours, followed by incubating with MTT reagent to
e means ± SE from three separated experiments.
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ethyl acetate (SI-2) and n-butanol (SI-3) to leave a water
layer (SI-4). The solvents were evaporated respectively,
and the residues were used throughout this study.
Reverse-phase high-performance liquid chromatography
(HPLC) analysis of flavonoids in S. involucrata
The determination of flavonoids from S. involucrata was
carried out by HPLC with a photodiary detector. The
HPLC system consisted of a Shimadzu LC-20AT solvent
delivery system, equipped with a SPD-M20A photodiode
array detector, set at 270 nm. Samples were injected with
SiL-20A autosample to separate on the TSK-Gel ODS-
100S column. The column was maintained at an ambientFigure 2 Effect of DHT on inhibition nitric oxide and pro-inflammator
RAW264.7 macrophage were pre-treated with DHT for 30 min, followed by
tion for 24 h, nitric oxide concentration in culture medium was assayed by
mRNA expression and secreted concentration in culture medium was assay
were determined by RT-PCR and ELISsA. The data was expressed as the m
significantly with the LPS-treated group only.temperature of 25°C. The flow rate of the system was
1.0 mL/min. The mobile phase consisted of solvent A
(0.3% formic acid) and solvent B (acetonitrile). The elution
profile for A was 0-10 min, with a linear gradient change
of 0-5%; 10-40 min, with a linear gradient change to 55%;
and maintained for another 10 min with a post run time
to equilibrate the column and for the baseline to return
to the normal and initial working conditions [2].
Chemicals and reagents
3,4-dihydroxyphenylacetic acid (DHPAA), 3,4-dihydroxytoluene
(DHT), 3-hydroxyphenylacetic acid (HPAA) and 4-hydroxy-
3-methoxyphenylacetic acid (homovanillic acid, HVA)
and 3-(4,5-Dimethylthiazol-2-yl)-2,5-diphenyl tetrazoliumy cytokines production in LPS-stimulated RAW264.7 macrophage.
stimulating with LPS (100 ng/ml) for 6 and 24 hours. (A) After incuba-
the Gress reaction. After incubation for 6 h, the (B) TNF-α and (C) IL-6
ed by RT-PCR and ELISA. (D) The levels of IL-1β mRNAs and protein
eans ± SE from three separated experiments. *P < 0.05, **P < 0.01,
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MO). LPS (from Escherichia coli 0111:B4), mouse anti-
bodies against mouse phospho-ERK1/2, phospho-JNK1/2,
phospho-p38, and actin were purchased from Sigma
(St. Louis, MO). Rabbit antibodies against mouse ERK1/2,
JNK1, p38, phospho-IκB-α, iNOS, COX-2, and HRP-second
antibodies were obtained from Santa Cruz Biotechnology
(Santa Cruz, CA). IL-1β, IL-6, and TNF-α ELISA kits
were purchased from R&D Systems (Minneapolis, MN).Cell culture
RAW 264.7 macrophages were obtained from the
American Type Culture Collection (Rockville, MD). The
cells were propagated in RPMI-1640 medium (Gibco
Laboratories, Grand Island, NY) supplemented with 10%
heat-inactivated fetal calf serum (Biological Industries Ltd,
Kibbutz Beit Haemek, Israel), and 2 mM L-glutamine
(Life Technologies, Carlsbad, CA) at 37°C in a 5% CO2
incubator.Figure 3 Effects of DHT on inhibition of COX-2 and iNOS expression i
were pre-treated with DHT for 30 min, followed by stimulating with LPS (1
were determined by Western blot analysis. (upper panel) RI (Relative intens
data was expressed as the means ± SE from three separated experiments. *Cell viability assays
Cell viability assay was performed by the MTT (3-[4,5-
dimethylthiazol-2-yl]-2,5 diphenyl tetrazolium bromide)
assay based on the conversion of MTT into formazan
crystals by living cells, which determines mitochondrial
activity. Cell was cultured in 96-well plate with 5000/well
confluence. Twenty-four hours after treatment, after re-
moving supernatant 100 μl MTT reagent was added for
1 h incubation. For measurement, 100 μl DMSO was added
in each well follow by ELISA reader detection at 570 nm.
Data are representative of three independent experiments.Enzyme-linked immunosorbent assay (ELISA)
ELISA was performed according to the previous study [30].
Briefly, 2 × 106 in 2 mL medium were seeded in 60 mm
dishes for treatment. Six hours after treatment, 50 μL
of biotinylated antibody and 50 μL of supernatant were
added to a stripwell plate precoated with antimouse
IL-1β, IL-6, and TNF-α antibodies and incubated atn LPS-stimulated RAW264.7 macrophage. RAW264.7 macrophage
00 ng/ml) for 24 hours. The protein levels of COX-2, iNOS and GAPDH
ity) was measured by the densitometry scanning (lower panel). The
P < 0.05, **P < 0.01, significantly with the LPS-treated group only.
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buffer, 100 μL of diluted HRP-conjugated streptavidin
concentrate was added to each well and the plate incu-
bated at room temperature for 30 min. The washing
process was repeated, then 100 μL of a premixed tetra-
methylbenzidine substrate solution was added to each
well and the reaction developed at room temperature in
the dark for 30 min. Following addition of 100 μL of
stop solution to each well, the absorbance was read in
a microplate reader at 450 nm. Data are representative
of three independent experiments.
NO measurement
1×105 cells was seeded into 24-well plate (Nunc, USA)
at the day before treatment. Twenty-four hours after
treatment, the supernatant was collected and NO meas-
urement was performed by Griess Reagent. Briefly, the
supernatant (100 μl) was reacted with 1% sulfanilamide
solution (50 μl) for 5 min in the dark. After incubation,
50 μl 0.1% NED solution was added and absorbance
was measured at 550 nm. The concentration of NO
was calculated by utilizing NaNO2 standard curve. Data
are representative of three independent experiments.
Western blot assay
After treatment, the cells were collected and lysed at 4°C
in lysis buffer (25 mM Tris-HCl, pH 7.5, 100 mM NaCl,
2.5 mM EDTA, 2.5 mM EGTA, 20 mM NaF, 1 mM
Na3VO4, 20 mM sodium β-glycerophosphate, 10 mM
sodium pyrophosphate, 0.5% Triton X-100) containingLPS (100 ng/ml) - +                 +                 +                 +                +








Figure 4 Effects of DHT on activation of MAPK pathway in LPS-stimul
treated with DHT for 30 min, followed by stimulating with LPS (100 ng/ml)
(ERK1/2, JNK1/2 and p38) were determined by Western blot analysis. (B) Qu
tometry scanning. The data was expressed as RI (relative intensity) and the
significantly with the LPS-treated group only.protease inhibitor cocktail (Sigma, St. Louis, MO), then
the whole cell lysate was separated by SDS-PAGE and
electrotransferred to a PVDF membrane. The membranes
were incubated for 1 h at room temperature in blocking
solution (5% nonfat milk in phosphate buffered saline
with 0.1% Tween 20), then incubated for 2 h at room
temperature with specific primary antibody in blocking
solution. After 3 washes in PBS with 0.1% Tween 20,
the membrane was incubated for 1 h at room temperature
with HRPconjugated secondary antibody in blocking buf-
fer and developed using an enhanced chemiluminescence
Western blot detection system.
Statistical analysis
All values are given as means ± S. E. Data analysis involved
one-way ANOVA with subsequent Scheffé test. * and **
indicate a significant difference at the level of p < 0.05 and
P < 0.01, respectively, compared to LPS alone.
Results and discussion
To test whether rutin and its’ metabolites can efficiently
inhibit inflammation, we measured nitric oxide (NO)
production, an inflammation marker, in LPS-stimulated
RAW 264.7 cells in the present of these compounds.
The result indicated 10 μM DHT had the most signifi-
cant inhibitory effect on NO production when compared
with other metabolites (Figure 1A). Therefore, we further
utilized DHT to address its biological effects and mecha-
nisms on inflammation. In the mention of cytotoxicity,























LPS (100ng/ml)        - +  +              +               +               +
DHT (µM)       0               0  1.25    2.5           5               10
(B)
ated RAW264.7 macrophage. RAW264.7 macrophage were pre-
for 30 min. (A) The phosphorylation and total protein levels of MAPK
antification of the level of phosphorylation measured by the densi-
means ± SE from three separated experiments. *P < 0.05, **P < 0.01,
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had low cytotoxicity. (Figure 1B). To evaluate the effect
of DHT on NO production precisely, we performed
NO measurement for RAW264.7 cell with different dose.
The result indicated that DHT can significantly reduce
NO generation after LPS treatment in a dose-dependent
manner from 1.25 to 10 μM (Figure 2A). In addition to
NO, we also test several inflammatory cytokines produc-
tion after LPS stimulation including TNF-α, IL-6 and
IL-1β. DHT at 5 and 10 mM can significantly reduce the
mRNA and protein expression levels of TNF-# (Figure 2B).
No significant effect was observed on IL-6 and IL-1b
mRNA and protein expression (Figure 2C and D). Taken
together, these results indicated that DHT can eliminate
LPS-induced NO and inflammatory cytokines produc-
tion majorly through TNF-α signaling without affecting
cell viability.
Since NO production can be catalyzed by inducible
NO synthase (iNOS), we further investigated the effect
of DHT on iNOS expression. The result showed that
DHT can significantly reduce iNOS expression in a dose
dependent manner. Similar results were obtained for
cyclooxygenase-2 (COX-2) (Figure 3). These resultsFigure 5 Effect of DHT on activation of NF-kB pathway in LPS-stimula
treated with DHT for 30 min, followed by stimulating with LPS (100 ng/ml)
and α-tubulin were determined by Western blot analysis. (B) The p65 subu
western blot analysis. RI (Relative intensity) was measured by the densitom
separated experiments. *P < 0.05, **P < 0.01, significantly with the LPS-treaindicated that the DHT was the principal metabolite of
rutin with potential anti-inflammatory activity. MAPK
signaling was one of the most important LPS-activated
pathways, therefore, we tested whether DHT can modu-
late LPS-stimulated downstream signaling of MAPK. The
results indicated that DHT had no effect on LPS mediated
JNK1/2, ERK1/2 as well as p38 signaling (Figure 4A-B).
The NF-κB, one of the critical transcription factors,
regulates the inflammatory-related gene expression in the
LPS-activated macrophages. In the resting macrophages,
NF-κB is sequestered in the cytoplasm as an inactive
precursor complex by its inhibitory protein, IκB. After
stimulation, IκB is phosphorylated by IκB kinase, ubi-
quitinated, and rapidly degraded through proteasomes
followed by NF-κB releasing. Released p65 subunit of
NF-κB is translocated from cytoplasm to nucleus and
activates numerous corresponding genes. We found that
DHT can significantly reduce the phosphorylation of
IκB-a in RAW 264.7 cells after LPS treatment (Figure 5A).
This leaded to accumulation of NF-κB (p65) in the cyto-
plasm and nuclear NF-κB (p65) reduction (Figure 5B).
These results indicated that DHT at least can attenuate
NF-κB signaling activation in macrophages after LPSted RAW264.7 macrophage. RAW264.7 macrophage were pre-
for 30 min. (A) The phosphorylation and total protein levels of IκB
nit of NF-kB in cytoplasm and p65 in nucleus were determined by
etry scanning. The data was expressed as the means ± SE from three
ted group only.
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can efficiently inhibit IκB-NFκB mediated inflammatory
response (Figure 6).
Inflammation not only participates in host defense
but also controls the pathogenesis of numerous diseases
including type 2 diabetes mellitus [31-34], atheroscler-
osis [35,36], obesity [31,36], silicosis [37], Alzheimer's
disease [38], gout [33,39] and kidney disease [40,41]. An
elevated level of circulating inflammatory cytokines, in
particular, and a combined elevation of IL-1 and IL-6,
constitute risk factors for the pathogenesis of type II dia-
betes mellitus [42]. Also, TNF-α was found in some meta-
bolic diseases [43,44]. Some genetic engineering animal
model further confirmed inflammatory progress had
impact in vascular disease [45]. Therefore, reduction of
inflammation may provide an alternative disease man-
agement in complementary medicine field.
In this study, we found that rutin and DHT, the phenol
derivative of rutin, can significantly reduce NO production
in inflammatory response of LPS-stimulated macrophages.
Although NO played a critical role in the host defense
on various pathogens, the overproduction of NO can be
harmful and result in septic shock, rheumatoid arth-
ritis, and autoimmune diseases [46]. Therefore, adju-
vant therapeutic agents that inhibit iNOS might be
useful in relieving these inflammatory conditions. In
this study, DHT can potentially inhibit iNOS as well
as COX-2 expression through its upstream signaling inFigure 6 Illustration of signaling for RAW264.7 macrophage anti-inflaLPS-stimulated macrophages. The dual intrinsic enzyme
activities of COX-2 catalyze 2 sequential reactions in the
metabolism of arachidonic acid (AA). In addition, the
COX-2 enzyme possesses a heme-containing active site
that provides peroxidase activity, which requires 2 elec-
trons (2e−) to become active. The peroxidase reaction
converts PGG2 to PGH2 by removing oxygen(s), (Ox),
which might be a source of oxygen radicals. Therefore,
as more AA is metabolized to PG by COX-2, more
electron donors are depleted and more oxygen radicals
are generated. The effect of DHT on COX-2 expression
also supported its potential role and application in physio-
logical inflammatory unbalance by health supplements.
The reduction of iNOS and COX-2 may be due to
transcription suppression. Among transcription factors,
NF-κB is a significant inflammation-related one for down-
stream gene activation including cytokines, chemokines,
adhesion molecules, and acute phase proteins [47]. In
addition, NF-κB is a redox-sensitive transcription factor
that regulates a multitude of inflammatory genes, includ-
ing cytokines, chemokines, adhesion molecules, and acute
phase proteins. Under basal conditions, NF-κB is inactive
by associated with inhibitory proteins in the cytoplasm
to prevent DNA binding for transcription activity. In
our study, after the treatment with DHT, the nucleic
NF-κB p65 was reduced while cytoplasmic one was
accumulated (Figure 5). Although the reduction of
iNOS and COX-2 may be the consequence of NF-κBmmatory effect by DHT.
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effects can’t be excluded due to wide contribution of
NF-κB. Therefore, DHT may affect the upstream molecu-
lar of IκB-NF-κB signaling, since the phosphorylation of
IκB was attenuated by DHT. To clarify the underlying
molecular networks, more experiments should be further
performed. On the other hand, in this study, we found
DHT had no influence on MAPK pathway (Figure 4) sug-
gested DHT reduced TNF-α expression majorly through
PI3K/AKT followed by NF-κB activation.
Conclusion
We demonstrated the anti-inflammatory activity of DHT,
the phenol derivative of rutin, via affecting IκB-NF-κB
signaling in macrophages and dissected its possible mech-
anism. The anti-inflammatory activity might be a basis for
therapeutic supplements innovation in complementary
and alternative medicine.
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